← Back to Clinical Trials
Recruiting NCT07538037

NCT07538037 Effects of Low-Intensity Blood Flow Restriction Training on Strength and Kicking Performance in Taekwondo Athletes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07538037
Status Recruiting
Phase
Sponsor Shanghai University of Sport
Condition Physical Performance
Study Type INTERVENTIONAL
Enrollment 18 participants
Start Date 2026-04-10
Primary Completion 2026-06-29

Eligibility & Interventions

Sex All sexes
Min Age 16 Years
Max Age 25 Years
Study Type INTERVENTIONAL
Interventions
LI-BFRTHIRT

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 18 participants in total. It began in 2026-04-10 with a primary completion date of 2026-06-29.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to investigate the effects of low-intensity blood flow restriction training (LI-BFRT) on lower-limb strength and kicking performance in taekwondo athletes. Blood flow restriction training is a method that partially restricts blood flow to the muscles during exercise, which may improve performance while reducing training load.

Eligibility Criteria

Inclusion Criteria: \- Taekwondo athletes aged 16-25 years National-level athletes (National Level 1 or higher); Minimum of 3 years of systematic taekwondo training experience; Free from lower-limb injury within the past 6 months; Able to complete the training intervention and testing procedures. Exclusion Criteria: \- History of cardiovascular, metabolic, or neurological disorders; Current musculoskeletal injury or pain affecting training; Participation in other structured resistance training programs during the study period; Use of medications or supplements that may affect physical performance Inability or unwillingness to provide informed consent.

Contact & Investigator

Central Contact

Yunzhou Hu, MSc

✉ 2421852028@sus.edu.cn

📞 +86 13532279646

Frequently Asked Questions

Who can join the NCT07538037 clinical trial?

This trial is open to participants of all sexes, aged 16 Years or older, up to 25 Years, studying Physical Performance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07538037 currently recruiting?

Yes, NCT07538037 is actively recruiting participants. Contact the research team at 2421852028@sus.edu.cn for enrollment information.

Where is the NCT07538037 trial being conducted?

This trial is being conducted at Shanghai, China.

Who is sponsoring the NCT07538037 clinical trial?

NCT07538037 is sponsored by Shanghai University of Sport. The trial plans to enroll 18 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology